Study in Patients With Asthma
|ClinicalTrials.gov Identifier: NCT00215397|
Recruitment Status : Completed
First Posted : September 22, 2005
Last Update Posted : November 11, 2010
|Condition or disease||Intervention/treatment||Phase|
|Asthma||Drug: Formoterol Fumarate||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||16 participants|
|Intervention Model:||Crossover Assignment|
|Primary Completion Date :||February 2003|
|Study Completion Date :||December 2005|
- The primary outcome variable is the measure of lung function.
- Secondary outcomes include change in lung function, as well as in vital signs.
- Physical exams, AE reporting, etc.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00215397
|United States, California|
|Long Beach, California, United States, 90806|
|United States, Colorado|
|Denver, Colorado, United States, 80206|
|United States, Oregon|
|Medford, Oregon, United States, 97504|